Synthesis of Alkylating agents

9,602 views 30 slides May 07, 2018
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

Synthesis of Alkylating agents


Slide Content

Synthesis of Alkylating Agents SAKSHAM PALAWAT 1

INTRODUCTION Cancer : It is defined as a disease characterized by uncontrolled proliferation of cell division and multiplication of own body’s cell. 2

Alkylating agents Alkylating agents are the compounds that have groups which form covalent bond with the cell substituents. A carbonium ion is a reactive intermediate. Most have two alkylating groups and can cross link two nucleophilic sites (mainly at N7 position of guanine) in the DNA. Cross linking prevents DNA replication through pairing of alkyl guanine Can also cause excision of guanine and chain breakage. Adverse effects : it includes – Myelosuppression Sterility increased risk of acute non lymphocytic leukemia 3

Alkylating Agents 4

5

Nitrogen Mustard 6

Mechlorethamine Synthesis: 7

Ifosfamide Synthesis: 8

Cyclophosphamide Synthesis: 9

Metabolism of Cyclophosphamide 10

Chlorambucil 11

Prodrug Approach of Chlorambucil 12

Melphalan 13

Mechanism If aromatic ring is attached to alkylating side chain 14

Nitrosoureas Mainly lipid soluble and can cross blood brain barrier Mostly used in the treatment of tumor in brain and in meninges Cause bone marrow depression Act as alkylating agent via formation of Aziridinium ring formation 15

Carmustine Synthesis: 16

Lomustine Synthesis: 17

Semustine Synthesis: 18

Estramustine Synthesis: 19

Alkyl Sulfonates Esters of alkane sulfonic acids with the general formula R-SO 2 -O-R‘ leads to the misreading of the DNA codes, single-strand breaks, and cross- -linking of DNA.    Used to treat chronic myelogenous leukemia (CML ). Also lead to discoloration of the skin, especially of the hands and nails, rashes and itching. 20

Busulfan Synthesis:   21

Ethylenimines used as an adjuvant to radiation therapy of retinoblastoma and injected into the carotid artery used in the palliative treatment of malignant neoplasm's Also used in the treatment of carcinoma of breast, ovaries, colon-rectum and rectum. It is found useful in the treatment of malignant lymphomas and bronchogenic carcinomas. The ‘drug’ also crosses the blood-brain barrier (BBB ). It has been observed that it undergoes absorption through serous membranes, bladder and pleura, to a certain degree . 22

Dacarbazine Synthesis: 23

Limitation – cause Photolysis 24

Temozolomide 25 It is an imidazotetrazine derivatives It is antitumor drug that is capable of entering the central nervous system and used to treat malignant brain tumor. Act as a  as a second-line treatment for astrocytoma and a first-line treatment for Glioblastoma multiforme .

Synthesis of Temozolomide 26

Altretamine Synthesis: 27

Thiotepa Synthesis: 28

References (1) Robert A. Weinberg. How Cancer Arises ,An Explosion of Research is Uncovering the Long- Hidden Molecular Underpinnings of Cancer-and Suggesting New Therapies. Sci. Am. 1996 , 62–68. (2) Beale, J. M.; John H. Block. Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry , 12th Editi.; David B. Troy, Ed.; Wolters Kluwer health, 2011. (3) Myles, A.; Penselau, C.; Friedman, O. M. Synthesis of Aldophosphamide, A Key Cyclophosphamide Metabolites. Tetrahedron Lett. 1977 , No. 29, 2475–2478. (4 ) Alagarsamy, V. Textbook of Medicinal Chemistry, Volume II ; 2010. (5) Singh, R. K.; Prasad, D. N.; Bhardwaj, T. R. Design, Synthesis, Chemical and Biological Evaluation of Brain Targeted Alkylating Agent Using Reversible Redox Prodrug Approach. Arab. J. Chem. 2017 , 10 (3), 420–429. (6) Ashutosh Kar. Medicinal Chemistry , fourth.; New Age International (P) Ltd.: New Delhi- 110002, 2007. (7) Iradyan, M. A.; Iradyan, N. S.; Stepanyan, G. M.; Arsenyan, F. G.; Garibdzhanyan, B. T. Antitumor Activity of Imidazole Derivatives: Dacarbazine and the New Alkylating Agent Imidazene (Review). Pharm. Chem. J. 2010 , 44 (4), 175–182. (8) Wanner, M. J.; Koomen, G.-J. A New Synthesis of Temozolomide. J. Chem. Soc. Perkin Trans. 1 2002 , 4 (16), 1877–1880. (9) Chand, M.; Shukla, A. Novel Synthesis of Altretamine and Their Process Impurities Using Imidazolium Type of Ionic Liquids. 1–9. (10) https://www.cancer.gov/about-cancer/understanding/what-is-cancer/types of cancer 29

Thank You! 30